April 28, 2020
Sumitomo Dainippon Pharma and Nihon Generic on April 27 launched Class I voluntary recalls for some lots of their diabetes drug metformin after detecting a level of the cancer-causing impurity N-nitrosodimethylamine (NDMA) that exceeds the limit set by the health...read more